观察罗格列酮对糖尿病大鼠内耳组织VEGF及ICAM—1表达的影响
2018-06-20高海涛穆俊晌张璞王欣赵京张勋
高海涛 穆俊晌 张璞 王欣 赵京 张勋

[摘要] 目的 就罗格利酮针对糖尿病大鼠内耳组织血管内皮生长因子(VEGF)及细胞间粘附分子—1(ICAM-1)水平的影响情况加以分析。方法 该次研究共计纳入糖尿病大鼠50只(按照相同方式进行动物模型建立),由该院在2016年2月—2017年6月自行培养,任意选取组内25只大鼠,给予罗格列酮处理,即观察组。余下25只大鼠则未采取其他药物处理。采集两组大鼠内耳组织样本,针对其VEGF以及ICAM-1水平比较。 结果 在未处理前,两组大鼠在VEGF以及ICAM-1水平,差异无统计学意义(P>0.05);而在使用罗格列酮处理后,观察组大鼠VEGF水平为(4.52±1.02)μg/L,对照组为(7.43±1.32)μg/L,差异有统计学意义(t=12.937,P=0.000);在ICAM-1水平上,观察组为(1.34±0.24)μg/L,对照组则为(2.56±0.31)μg/L,差异有统计学意义(t=9.927,P=0.000)。 结论 罗格列酮可有效针对糖尿病大鼠体内VEGF以及ICAM水平进行控制,进而达到对糖尿病所导致内耳微血管病变治疗的效果。
[关键词] 罗格列酮;糖尿病;VEGF;ICAM-1
[中图分类号] R4 [文献标识码] A [文章编号] 1674-0742(2018)03(a)-0017-03
Observation of the Effect of Rosiglitazone on the Expression of VEGF and ICAM-1 in the Inner Ear of Diabetic Rats
GAO Hai-tao, MU Jun-shang, ZHANG Pu, WANG Xin, ZHAO Jing, ZHANG Xun
Third Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, 050051 China
[Abstract] Objective The effects of rosiglitazone on the levels of vascular endothelial growth factor (VEGF) and intercellular adhesion molecule-1 (ICAM-1) in the inner ear tissues of diabetic rats were analyzed. Methods A total of 50 diabetic rats (according to the same animal model) were set up in this study from February 2016 to June 2017, and 25 rats were selected and treated with rosiglitazone as the observation group. The remaining 25 rats were not treated with other drugs. Samples of the inner ear tissue of two groups of rats were collected and compared to their VEGF and ICAM-1 levels. Results In the untreated group, two rats in the VEGF and ICAM-1 level had no significant differences(P>0.05);and in the use of rosiglitazone treatment, the level of VEGF group rats (4.52±1.02)μg/L, the control group (7.43±1.32)μg/L,the difference was statistically significant(t=12.937,P=0.000)。In ICAM-1 on the level of the observation group was (1.34±0.24)μg/L, the control group was (2.56±0.31)μg/L,the difference was statistically significant(t=9.927,P=0.000). Conclusion Rosiglitazone can effectively control the level of VEGF and ICAM in diabetic rats, so as to achieve the effect of diabetic microangiopathy.
[Key words] Rosiglitazone; Diabetes; VEGF; ICAM-1
糖尿病屬于我国主要慢性疾病,且在居民不良生活习惯以及饮食方式等方面因素的作用下,糖尿病的发生率更以极快的速度在增加。目前,临床尚缺乏对于该症的根治对策,需要长时间借助药物针对血糖水平加以控制[1-2]。其中内耳血管病变最为常见,而该并发症诱发机制临床尚未形成统一定论。借助罗格列酮针对该症进行治疗已逐步在临床得到推广[3-4]。该次研究以2016年2月—2017年6月自行培养50只大鼠,针对该药在改善内耳组织VEGF及ICAM-1表达水平方面的作用加以分析,现报道如下。……p>
